HAM
EBS icon

Highstreet Asset Management’s Emergent Biosolutions EBS Stock Holding History

Highstreet Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Hold
45
– – ﹤0.01% 584
2019
Q3 		$2K Hold
45
– – ﹤0.01% 353
2019
Q2 		$2K Hold
45
– – ﹤0.01% 338
2019
Q1 		$2K Hold
45
– – ﹤0.01% 352
2018
Q4 		$3K Buy
+45
New +$2.9K ﹤0.01% 290

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Highstreet Asset Management's EBS Position: Q4 2019 in Review

Highstreet Asset Management held its Emergent Biosolutions (EBS) position steady in Q4 2019 at 45 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #584.

Highstreet Asset Management first reported a position in EBS in Q4 2018 and has held it in 5 quarters since. The position peaked at $3K in Q4 2018. 236 funds tracked by Wall St. Rank hold EBS as of Q4 2019.

  • Highstreet Asset Management held 45 shares of Emergent Biosolutions worth $2K as of Q4 2019.
  • Highstreet Asset Management left its Emergent Biosolutions share count unchanged in Q4 2019.
  • Emergent Biosolutions made up ﹤0.01% of Highstreet Asset Management's portfolio in Q4 2019, its #584 holding.
  • Highstreet Asset Management first reported a position in Emergent Biosolutions in Q4 2018 and has held it in 5 quarters since.
  • Highstreet Asset Management's Emergent Biosolutions position peaked at $3K in Q4 2018.
  • 236 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2019.

Based on Highstreet Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.